Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhenyuan Huanwu traditional Chinese herbal decoction is a multi-ingredient herbal formulation developed by the Guangdong Provincial Hospital of Chinese Medicine for the treatment of post-stroke fatigue (PSF). Based on Traditional Chinese Medicine (TCM) principles, it is specifically indicated for patients with qi deficiency syndrome, a common pattern in PSF characterized by exhaustion and lack of energy. The decoction aims to tonify qi and improve functional recovery. It is currently being studied in multicenter randomized controlled trials to compare its clinical efficacy and safety profile with a more modern granule formulation (Zhenyuan Huanwu granule).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhenyuan Huanwu traditional Chinese herbal decoction.